Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy Thorne, Nevan J. Krogan, Jyoti Batra et al.|Nature|2021Cited by 405
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M. White, Adolfo García‐Sastre, Romel Rosales et al.|Science|2021Cited by 364
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tia A. Tummino, Brian K. Shoichet, Veronica V. Rezelj et al.|Science|2021Cited by 223